Drug Trial Radar · NCT06716281
Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis
Last checked: Nov 20, 2026Latest source record: Dec 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
398
Planned (sponsor's estimate)
Start
Jan 5, 2024
Primary completion
Dec 31, 2025
Study completion Dec 31, 2025
Sponsor
- Lead sponsor
- Shanghai IxCell Biotechnology Co., LTDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 4, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy of IxCell hUC-MSC-O in the treatment of patients with knee osteoarthritis. To evaluate the safety of IxCell hUC-MSC-O in the treatment of patients with knee osteoarthritis.
Conditions
- Knee Osteoarthritis
Interventions
Human umbilical cord mesenchymal stem cellsBiological
a single intra-articular injection of IxCell hUC-MSC-O at a dose of 5.0×10\^7 cells with a volume of 2.0 mL
PlaceboBiological
Sodium Chloride Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- WOMAC total scoreTime frame: 48 week
- cartilage damageTime frame: 48 week
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.